These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28646030)

  • 1. Metabolic remodeling in hypertrophied and failing myocardium: a review.
    Peterzan MA; Lygate CA; Neubauer S; Rider OJ
    Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H597-H616. PubMed ID: 28646030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reprogramming via PPARα signaling in cardiac hypertrophy and failure: From metabolomics to epigenetics.
    Warren JS; Oka SI; Zablocki D; Sadoshima J
    Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H584-H596. PubMed ID: 28646024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a causal link between intracellular Na elevation and metabolic remodelling in cardiac hypertrophy?
    Aksentijevic D; O'Brien BA; Eykyn TR; Shattock MJ
    Biochem Soc Trans; 2018 Aug; 46(4):817-827. PubMed ID: 29970448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial Creatine Kinase Attenuates Pathologic Remodeling in Heart Failure.
    Keceli G; Gupta A; Sourdon J; Gabr R; Schär M; Dey S; Tocchetti CG; Stuber A; Agrimi J; Zhang Y; Leppo M; Steenbergen C; Lai S; Yanek LR; O'Rourke B; Gerstenblith G; Bottomley PA; Wang Y; Paolocci N; Weiss RG
    Circ Res; 2022 Mar; 130(5):741-759. PubMed ID: 35109669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart spotting.
    el Azzouzi H; De Windt LJ
    Basic Res Cardiol; 2008 May; 103(3):228-31. PubMed ID: 18274799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach.
    Lai L; Leone TC; Keller MP; Martin OJ; Broman AT; Nigro J; Kapoor K; Koves TR; Stevens R; Ilkayeva OR; Vega RB; Attie AD; Muoio DM; Kelly DP
    Circ Heart Fail; 2014 Nov; 7(6):1022-31. PubMed ID: 25236884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose is preferentially utilized for biomass synthesis in pressure-overloaded hearts: evidence from fatty acid-binding protein-4 and -5 knockout mice.
    Umbarawan Y; Syamsunarno MRAA; Koitabashi N; Yamaguchi A; Hanaoka H; Hishiki T; Nagahata-Naito Y; Obinata H; Sano M; Sunaga H; Matsui H; Tsushima Y; Suematsu M; Kurabayashi M; Iso T
    Cardiovasc Res; 2018 Jul; 114(8):1132-1144. PubMed ID: 29554241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Coordination of Physiological and Pathological Cardiac Remodeling.
    Gibb AA; Hill BG
    Circ Res; 2018 Jun; 123(1):107-128. PubMed ID: 29929976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic remodelling of the failing heart: beneficial or detrimental?
    van Bilsen M; van Nieuwenhoven FA; van der Vusse GJ
    Cardiovasc Res; 2009 Feb; 81(3):420-8. PubMed ID: 18854380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy during cardiac remodeling.
    Nishida K; Otsu K
    J Mol Cell Cardiol; 2016 Jun; 95():11-8. PubMed ID: 26678624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The myocardium in congestive heart failure.
    Katz AM
    Am J Cardiol; 1989 Jan; 63(2):12A-16A. PubMed ID: 2521266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac metabolism in heart failure: implications beyond ATP production.
    Doenst T; Nguyen TD; Abel ED
    Circ Res; 2013 Aug; 113(6):709-24. PubMed ID: 23989714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy modulation: a potential therapeutic approach in cardiac hypertrophy.
    Wang X; Cui T
    Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H304-H319. PubMed ID: 28576834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of energy substrate metabolism in normal and hypertrophied heart.
    Tian R
    Curr Hypertens Rep; 2003 Dec; 5(6):454-8. PubMed ID: 14594563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcellular remodeling as a viable target for the treatment of congestive heart failure.
    Dhalla NS; Dent MR; Tappia PS; Sethi R; Barta J; Goyal RK
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):31-45. PubMed ID: 16703218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcellular remodelling may induce cardiac dysfunction in congestive heart failure.
    Dhalla NS; Saini-Chohan HK; Rodriguez-Leyva D; Elimban V; Dent MR; Tappia PS
    Cardiovasc Res; 2009 Feb; 81(3):429-38. PubMed ID: 18852252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of physiological and pathological cardiac hypertrophy.
    Nakamura M; Sadoshima J
    Nat Rev Cardiol; 2018 Jul; 15(7):387-407. PubMed ID: 29674714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Energy metabolism in heart failure and remodelling.
    Ingwall JS
    Cardiovasc Res; 2009 Feb; 81(3):412-9. PubMed ID: 18987051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of subcellular remodeling in cardiac dysfunction due to congestive heart failure.
    Babick AP; Dhalla NS
    Med Princ Pract; 2007; 16(2):81-9. PubMed ID: 17303941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix revisited: mechanisms linking energy substrate metabolism to the function of the heart.
    Carley AN; Taegtmeyer H; Lewandowski ED
    Circ Res; 2014 Feb; 114(4):717-29. PubMed ID: 24526677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.